Intracoronary Abciximab With Clearway Catheter (IC-CLEARLY)
This study has been terminated.
(the study was stopped because the sample size was very difficult to achieve.)
First Posted: May 6, 2009
Last Update Posted: January 4, 2013
Information provided by (Responsible Party):
Gennaro Sardella, University of Roma La Sapienza
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||June 2011|
|Primary Completion Date:||December 2010 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Sardella G, Sangiorgi GM, Mancone M, Colantonio R, Donahue M, Politi L, Bucciarelli-Ducci C, Carbone I, Francone M, Ligabue G, Fiocchi F, Di Roma A, Benedetti G, Lucisano L, Stio RE, Agati L, Modena MG, Genuini I, Fedele F, Gibson M. A multicenter randomized study to evaluate intracoronary abciximab with the ClearWay catheter to improve outcomes with Lysis (IC ClearLy): trial study design and rationale. J Cardiovasc Med (Hagerstown). 2010 Jul;11(7):529-35. doi: 10.2459/JCM.0b013e3283341c1c. Erratum in: J Cardiovasc Med (Hagerstown). 2015 Apr;16(4):320. Ducci, Chiara B [corrected to Bucciarelli-Ducci, C].